Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

Cosmos Health (COSM) Shares Outstanding (2016 - 2025)

Cosmos Health's Shares Outstanding history spans 13 years, with the latest figure at $41.2 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $41.2 million for Q4 2025, up 73.72% from a year ago — trailing twelve months through Dec 2025 was $41.2 million (up 73.72% YoY), and the annual figure for FY2025 was $41.2 million, up 73.72%.
  • Shares Outstanding for Q4 2025 was $41.2 million at Cosmos Health, up from $32.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $41.2 million in Q4 2025 to a low of $15497.0 in Q4 2021.
  • The 5-year median for Shares Outstanding is $12.0 million (2023), against an average of $13.2 million.
  • The sharpest move saw Shares Outstanding plummeted 99.99% in 2022, then skyrocketed 114980.49% in 2024.
  • Year by year, Shares Outstanding stood at $701780.0 in 2021, then soared by 1411.22% to $10.6 million in 2022, then soared by 50.7% to $16.0 million in 2023, then soared by 48.22% to $23.7 million in 2024, then soared by 73.72% to $41.2 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $41.2 million, $31.9 million, and $29.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.